Bifidobacterium breve

DB16549Investigational

Bifidobacterium breve: Overview.

Resolves to

Compound
UNIIL07O8T40TE
Clinical / RWD
RxNorm2110011

What you can answer from here — as of March 03, 2026

18Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in

Which companies are running trials of Bifidobacterium breve, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In